You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bbi503

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Hepatocellular Carcinoma Trial in Chiba, Etc. (BBI503, Sorafenib)

Completed
  • Advanced Solid Tumors
  • Hepatocellular Carcinoma
  • Chiba, Etc., Japan
    5 Sites
Apr 9, 2022

Urologic Malignancies, Renal Cell Carcinoma, Urothelial Carcinoma Trial (BBI503)

Withdrawn
  • Urologic Malignancies
  • +2 more
  • BBI503
  • (no location specified)
Apr 4, 2022

Gastrointestinal Stromal Tumors Trial in Toronto (BBI503)

Terminated
  • Gastrointestinal Stromal Tumors
  • BBI503
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 4, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma Trial in Calgary, Ottawa, Toronto (BBI503)

Completed
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
  • BBI503
  • Calgary, Alberta, Canada
  • +2 more
Apr 4, 2022

Cancer Trial in Canada, United States (BBI503, Capecitabine, Doxorubicin)

Completed
  • Cancer
  • BBI503
  • +6 more
  • Fort Wayne, Indiana
  • +7 more
Apr 4, 2022

Cancer, Advanced Solid Tumors Trial in United States (BBI608, BBI503)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +10 more
Apr 4, 2022

Hepatocellular Carcinoma Trial in United States (BBI608, BBI503, Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +28 more
Apr 4, 2022

Cancer, Advanced Solid Tumors Trial in Canada, United States (BBI503)

Completed
  • Cancer, Advanced Solid Tumors
  • BBI503
  • Scottsdale, Arizona
  • +18 more
Apr 4, 2022